A carregar...
Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
BACKGROUND: Bevacizumab has an important role in first-line treatment of metastatic colorectal cancer. However, clinical trials studying its effect have involved distinct chemotherapy regimens with divergent results. The aim of this meta-analysis is to gather current data and evaluate not only the e...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3350458/ https://ncbi.nlm.nih.gov/pubmed/22414244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-89 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|